With a strong clinical-stage pipeline, Agenus harnesses a mix of proprietary antibody platforms, such as Retrocyte Show™ and SECANT®, and progressive cell therapy approaches, positioning alone for a vital contributor during the biotechnology and immunotherapy arena. Our expense manageme